Join
Live feed
·
INSIDERFilingvia Quantisnow
Timber Pharmaceuticals Inc. logo

SEC Form 4: TardiMed Sciences LLC sold $221,480 worth of Common Stock (174,915 units at $1.27), decreasing direct ownership by 4% to 4,609,067 units

ByQuantisnow·Wall Street's wire, on your screen.
TMBR· Timber Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TMBR (Timber Pharmaceuticals Inc.) and more on Quantisnow.